BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
106.62
+1.08 (1.02%)
At close: Feb 6, 2026, 4:00 PM EST
107.16
+0.54 (0.51%)
After-hours: Feb 6, 2026, 7:49 PM EST
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $26.75 billion as of February 6, 2026. Its market cap has decreased by -8.62% in one year.
Market Cap
26.75B
Enterprise Value
10.00B
1-Year Change
-8.62%
Ranking
Category
Stock Price
$106.62
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $26.75B, an increase of 793.30%. That is a compound annual growth rate of 41.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 26.75B | 16.87% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 51.67B |
| Alnylam Pharmaceuticals | 43.76B |
| BeOne Medicines AG | 38.40B |
| Insmed | 32.21B |
| Royalty Pharma | 25.46B |
| Incyte | 20.17B |
| Genmab | 19.33B |
| Revolution Medicines | 18.59B |